nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—FDPS—prostate gland—prostate cancer	0.0125	0.224	CbGeAlD
Ibandronate—FDPS—seminal vesicle—prostate cancer	0.0105	0.189	CbGeAlD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—MBTPS1—prostate cancer	0.01	0.0779	CbGpPWpGaD
Ibandronate—FDPS—renal system—prostate cancer	0.00849	0.152	CbGeAlD
Ibandronate—FDPS—urethra—prostate cancer	0.00834	0.15	CbGeAlD
Ibandronate—FDPS—SREBP signalling—MBTPS1—prostate cancer	0.00813	0.0631	CbGpPWpGaD
Ibandronate—FDPS—bone marrow—prostate cancer	0.00642	0.115	CbGeAlD
Ibandronate—FDPS—testis—prostate cancer	0.00549	0.0985	CbGeAlD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—NCOA2—prostate cancer	0.00457	0.0354	CbGpPWpGaD
Ibandronate—FDPS—lymph node—prostate cancer	0.00398	0.0714	CbGeAlD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—NCOA1—prostate cancer	0.00385	0.0299	CbGpPWpGaD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—RXRA—prostate cancer	0.00366	0.0284	CbGpPWpGaD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—NCOA2—prostate cancer	0.00365	0.0283	CbGpPWpGaD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—NCOA1—prostate cancer	0.00307	0.0239	CbGpPWpGaD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—RXRA—prostate cancer	0.00292	0.0227	CbGpPWpGaD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—PPARA—prostate cancer	0.0028	0.0217	CbGpPWpGaD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—PPARA—prostate cancer	0.00223	0.0173	CbGpPWpGaD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—CREBBP—prostate cancer	0.00222	0.0172	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—SIRT1—prostate cancer	0.00217	0.0169	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—LPL—prostate cancer	0.00205	0.0159	CbGpPWpGaD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—CREBBP—prostate cancer	0.00177	0.0138	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—GRHL1—prostate cancer	0.00172	0.0133	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CBR1—prostate cancer	0.00172	0.0133	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—MBTPS1—prostate cancer	0.0015	0.0117	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—INS—prostate cancer	0.00147	0.0114	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—AMACR—prostate cancer	0.00142	0.0111	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—DEGS1—prostate cancer	0.00142	0.0111	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—SRD5A2—prostate cancer	0.00142	0.0111	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	0.00136	0.0106	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	0.00121	0.0094	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	0.00114	0.00884	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	0.00111	0.0086	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	0.00108	0.00838	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	0.00103	0.008	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	0.00103	0.008	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—HAO1—prostate cancer	0.000939	0.00729	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	0.000876	0.0068	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	0.00084	0.00652	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	0.000808	0.00627	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	0.00078	0.00606	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CSAD—prostate cancer	0.000766	0.00594	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CBR1—prostate cancer	0.000766	0.00594	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GRHL1—prostate cancer	0.000766	0.00594	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ADI1—prostate cancer	0.000766	0.00594	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—TST—prostate cancer	0.000766	0.00594	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PSAT1—prostate cancer	0.000766	0.00594	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	0.000748	0.00581	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	0.000734	0.0057	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—PIK3CA—prostate cancer	0.000723	0.00561	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—UGT2B17—prostate cancer	0.000712	0.00553	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GRHPR—prostate cancer	0.000712	0.00553	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CKMT2—prostate cancer	0.000712	0.00553	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—UGT2B15—prostate cancer	0.000712	0.00553	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	0.000696	0.0054	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—MED12—prostate cancer	0.000684	0.00531	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GSTM3—prostate cancer	0.000669	0.0052	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—AOX1—prostate cancer	0.000669	0.0052	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PGAM2—prostate cancer	0.000669	0.0052	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—NAGLU—prostate cancer	0.000669	0.0052	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SULT2B1—prostate cancer	0.000669	0.0052	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—MBTPS1—prostate cancer	0.000669	0.0052	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—RFK—prostate cancer	0.000669	0.0052	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	0.000654	0.00508	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—AMACR—prostate cancer	0.000634	0.00493	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CYP3A43—prostate cancer	0.000634	0.00493	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—NAT1—prostate cancer	0.000634	0.00493	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SRD5A2—prostate cancer	0.000634	0.00493	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—DEGS1—prostate cancer	0.000634	0.00493	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	0.000624	0.00484	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	0.00062	0.00481	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—HSD17B1—prostate cancer	0.000605	0.0047	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	0.000605	0.0047	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—AKT1—prostate cancer	0.000591	0.00459	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	0.000582	0.00452	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	0.000579	0.00449	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	0.000573	0.00445	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	0.000546	0.00424	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—HPGD—prostate cancer	0.000539	0.00419	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—B4GALT4—prostate cancer	0.000539	0.00419	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—TNFRSF21—prostate cancer	0.000507	0.00394	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—MTAP—prostate cancer	0.000493	0.00383	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CYP7B1—prostate cancer	0.000493	0.00383	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	0.000482	0.00374	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SULT1E1—prostate cancer	0.000481	0.00373	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SRD5A1—prostate cancer	0.000481	0.00373	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	0.000467	0.00363	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	0.00046	0.00357	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—HSD17B3—prostate cancer	0.000459	0.00356	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ACSL4—prostate cancer	0.000459	0.00356	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	0.000453	0.00352	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PHGDH—prostate cancer	0.00044	0.00341	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—UMPS—prostate cancer	0.00044	0.00341	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ARG2—prostate cancer	0.00044	0.00341	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	0.000438	0.0034	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—LDHB—prostate cancer	0.000431	0.00335	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CYP3A5—prostate cancer	0.000423	0.00329	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—UCP3—prostate cancer	0.000409	0.00317	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PDHA1—prostate cancer	0.000409	0.00317	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GSTA3—prostate cancer	0.000409	0.00317	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—TCN2—prostate cancer	0.000409	0.00317	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—HSD3B1—prostate cancer	0.00039	0.00303	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SLC22A3—prostate cancer	0.00039	0.00303	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—LPL—prostate cancer	0.000378	0.00294	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—TBXAS1—prostate cancer	0.000374	0.0029	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GSTA4—prostate cancer	0.000374	0.0029	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	0.000365	0.00284	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GSTA2—prostate cancer	0.000364	0.00283	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SULT1A1—prostate cancer	0.00036	0.00279	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ABCG5—prostate cancer	0.00036	0.00279	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GSTA1—prostate cancer	0.000352	0.00273	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—NAT2—prostate cancer	0.000348	0.0027	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GSTO1—prostate cancer	0.000348	0.0027	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—HSD3B2—prostate cancer	0.000348	0.0027	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	0.000334	0.00259	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—LRP2—prostate cancer	0.000333	0.00259	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PLCB2—prostate cancer	0.000333	0.00259	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CYP2C18—prostate cancer	0.000333	0.00259	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—P4HB—prostate cancer	0.000327	0.00254	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SLC22A1—prostate cancer	0.000318	0.00247	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	0.000314	0.00244	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SULT2A1—prostate cancer	0.00031	0.00241	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—MED12—prostate cancer	0.000305	0.00237	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GNG5—prostate cancer	0.000302	0.00235	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—NCOA3—prostate cancer	0.000291	0.00226	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	0.000286	0.00222	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—HPGDS—prostate cancer	0.000278	0.00216	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CYP2C19—prostate cancer	0.000276	0.00214	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ACHE—prostate cancer	0.00027	0.00209	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GSTT1—prostate cancer	0.00027	0.00209	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CYP2A6—prostate cancer	0.000266	0.00207	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	0.000265	0.00206	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—AKR1C3—prostate cancer	0.000259	0.00201	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PRKACB—prostate cancer	0.000258	0.002	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CYP17A1—prostate cancer	0.000255	0.00198	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	0.000252	0.00195	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—NCOA2—prostate cancer	0.000243	0.00189	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SLC5A5—prostate cancer	0.000232	0.0018	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CYP2E1—prostate cancer	0.000227	0.00176	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—NQO1—prostate cancer	0.000224	0.00174	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—TH—prostate cancer	0.000221	0.00171	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	0.000219	0.0017	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CYP3A4—prostate cancer	0.000218	0.0017	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	0.000217	0.00169	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CYP1B1—prostate cancer	0.000215	0.00167	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GGT1—prostate cancer	0.000208	0.00161	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—NCOA1—prostate cancer	0.000205	0.00159	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CYP19A1—prostate cancer	0.000202	0.00157	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—RXRA—prostate cancer	0.000195	0.00151	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	0.00019	0.00147	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—COMT—prostate cancer	0.000188	0.00146	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GSTP1—prostate cancer	0.000187	0.00145	CbGpPWpGaD
Ibandronate—Nervous system disorder—Docetaxel—prostate cancer	0.000185	0.000227	CcSEcCtD
Ibandronate—Ill-defined disorder—Prednisone—prostate cancer	0.000185	0.000227	CcSEcCtD
Ibandronate—Rash—Estradiol—prostate cancer	0.000185	0.000227	CcSEcCtD
Ibandronate—Infestation NOS—Doxorubicin—prostate cancer	0.000185	0.000227	CcSEcCtD
Ibandronate—Infestation—Doxorubicin—prostate cancer	0.000185	0.000227	CcSEcCtD
Ibandronate—Dermatitis—Estradiol—prostate cancer	0.000185	0.000227	CcSEcCtD
Ibandronate—Anaemia—Prednisone—prostate cancer	0.000185	0.000226	CcSEcCtD
Ibandronate—FDPS—Metabolism—ITPR1—prostate cancer	0.000184	0.00143	CbGpPWpGaD
Ibandronate—Headache—Estradiol—prostate cancer	0.000184	0.000225	CcSEcCtD
Ibandronate—Skin disorder—Docetaxel—prostate cancer	0.000184	0.000225	CcSEcCtD
Ibandronate—Angioedema—Prednisone—prostate cancer	0.000182	0.000224	CcSEcCtD
Ibandronate—Renal failure—Doxorubicin—prostate cancer	0.000182	0.000223	CcSEcCtD
Ibandronate—Infection—Capecitabine—prostate cancer	0.000182	0.000223	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—EP300—prostate cancer	0.000181	0.0014	CbGpPWpGaD
Ibandronate—Urticaria—Etoposide—prostate cancer	0.000181	0.000222	CcSEcCtD
Ibandronate—Haemoglobin—Epirubicin—prostate cancer	0.00018	0.000221	CcSEcCtD
Ibandronate—Stomatitis—Doxorubicin—prostate cancer	0.00018	0.000221	CcSEcCtD
Ibandronate—Malaise—Prednisone—prostate cancer	0.00018	0.000221	CcSEcCtD
Ibandronate—Shock—Capecitabine—prostate cancer	0.00018	0.000221	CcSEcCtD
Ibandronate—Body temperature increased—Etoposide—prostate cancer	0.00018	0.00022	CcSEcCtD
Ibandronate—Abdominal pain—Etoposide—prostate cancer	0.00018	0.00022	CcSEcCtD
Ibandronate—Urinary tract infection—Doxorubicin—prostate cancer	0.00018	0.00022	CcSEcCtD
Ibandronate—Nervous system disorder—Capecitabine—prostate cancer	0.000179	0.00022	CcSEcCtD
Ibandronate—Vertigo—Prednisone—prostate cancer	0.000179	0.00022	CcSEcCtD
Ibandronate—Haemorrhage—Epirubicin—prostate cancer	0.000179	0.00022	CcSEcCtD
Ibandronate—Pharyngitis—Epirubicin—prostate cancer	0.000178	0.000218	CcSEcCtD
Ibandronate—Skin disorder—Capecitabine—prostate cancer	0.000178	0.000218	CcSEcCtD
Ibandronate—Sweating—Doxorubicin—prostate cancer	0.000177	0.000217	CcSEcCtD
Ibandronate—Urinary tract disorder—Epirubicin—prostate cancer	0.000177	0.000217	CcSEcCtD
Ibandronate—Hyperhidrosis—Capecitabine—prostate cancer	0.000177	0.000217	CcSEcCtD
Ibandronate—Oedema peripheral—Epirubicin—prostate cancer	0.000177	0.000217	CcSEcCtD
Ibandronate—Connective tissue disorder—Epirubicin—prostate cancer	0.000176	0.000216	CcSEcCtD
Ibandronate—Urethral disorder—Epirubicin—prostate cancer	0.000176	0.000216	CcSEcCtD
Ibandronate—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000175	0.000214	CcSEcCtD
Ibandronate—Nausea—Estradiol—prostate cancer	0.000174	0.000214	CcSEcCtD
Ibandronate—Vomiting—Mitoxantrone—prostate cancer	0.000174	0.000213	CcSEcCtD
Ibandronate—FDPS—Metabolism—TYMS—prostate cancer	0.000174	0.00135	CbGpPWpGaD
Ibandronate—Hypertension—Prednisone—prostate cancer	0.000172	0.000211	CcSEcCtD
Ibandronate—Rash—Mitoxantrone—prostate cancer	0.000172	0.000211	CcSEcCtD
Ibandronate—Dermatitis—Mitoxantrone—prostate cancer	0.000172	0.000211	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000172	0.000211	CcSEcCtD
Ibandronate—FDPS—Metabolism—GSTM1—prostate cancer	0.000172	0.00133	CbGpPWpGaD
Ibandronate—Headache—Mitoxantrone—prostate cancer	0.000171	0.00021	CcSEcCtD
Ibandronate—Insomnia—Docetaxel—prostate cancer	0.000171	0.00021	CcSEcCtD
Ibandronate—Myalgia—Prednisone—prostate cancer	0.00017	0.000208	CcSEcCtD
Ibandronate—Arthralgia—Prednisone—prostate cancer	0.00017	0.000208	CcSEcCtD
Ibandronate—Paraesthesia—Docetaxel—prostate cancer	0.00017	0.000208	CcSEcCtD
Ibandronate—Anxiety—Prednisone—prostate cancer	0.000169	0.000208	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000169	0.000207	CcSEcCtD
Ibandronate—FDPS—Metabolism—LPL—prostate cancer	0.000169	0.00131	CbGpPWpGaD
Ibandronate—Discomfort—Prednisone—prostate cancer	0.000168	0.000206	CcSEcCtD
Ibandronate—Eye disorder—Epirubicin—prostate cancer	0.000168	0.000206	CcSEcCtD
Ibandronate—Hypersensitivity—Etoposide—prostate cancer	0.000168	0.000205	CcSEcCtD
Ibandronate—Haemoglobin—Doxorubicin—prostate cancer	0.000167	0.000205	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000167	0.000204	CcSEcCtD
Ibandronate—Cardiac disorder—Epirubicin—prostate cancer	0.000167	0.000204	CcSEcCtD
Ibandronate—Dyspepsia—Docetaxel—prostate cancer	0.000166	0.000204	CcSEcCtD
Ibandronate—Haemorrhage—Doxorubicin—prostate cancer	0.000166	0.000204	CcSEcCtD
Ibandronate—Insomnia—Capecitabine—prostate cancer	0.000165	0.000203	CcSEcCtD
Ibandronate—Pharyngitis—Doxorubicin—prostate cancer	0.000165	0.000202	CcSEcCtD
Ibandronate—Paraesthesia—Capecitabine—prostate cancer	0.000164	0.000201	CcSEcCtD
Ibandronate—Decreased appetite—Docetaxel—prostate cancer	0.000164	0.000201	CcSEcCtD
Ibandronate—Urinary tract disorder—Doxorubicin—prostate cancer	0.000164	0.000201	CcSEcCtD
Ibandronate—Oedema peripheral—Doxorubicin—prostate cancer	0.000164	0.000201	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000163	0.0002	CcSEcCtD
Ibandronate—Asthenia—Etoposide—prostate cancer	0.000163	0.0002	CcSEcCtD
Ibandronate—Connective tissue disorder—Doxorubicin—prostate cancer	0.000163	0.0002	CcSEcCtD
Ibandronate—Anaphylactic shock—Prednisone—prostate cancer	0.000163	0.0002	CcSEcCtD
Ibandronate—Fatigue—Docetaxel—prostate cancer	0.000163	0.0002	CcSEcCtD
Ibandronate—Angiopathy—Epirubicin—prostate cancer	0.000163	0.0002	CcSEcCtD
Ibandronate—FDPS—Metabolism—CYP1A1—prostate cancer	0.000163	0.00126	CbGpPWpGaD
Ibandronate—Urethral disorder—Doxorubicin—prostate cancer	0.000163	0.0002	CcSEcCtD
Ibandronate—Nausea—Mitoxantrone—prostate cancer	0.000162	0.000199	CcSEcCtD
Ibandronate—Immune system disorder—Epirubicin—prostate cancer	0.000162	0.000199	CcSEcCtD
Ibandronate—Infection—Prednisone—prostate cancer	0.000162	0.000199	CcSEcCtD
Ibandronate—Mediastinal disorder—Epirubicin—prostate cancer	0.000162	0.000198	CcSEcCtD
Ibandronate—Pain—Docetaxel—prostate cancer	0.000162	0.000198	CcSEcCtD
Ibandronate—Constipation—Docetaxel—prostate cancer	0.000162	0.000198	CcSEcCtD
Ibandronate—FDPS—Metabolism—ERCC2—prostate cancer	0.000161	0.00125	CbGpPWpGaD
Ibandronate—Dyspepsia—Capecitabine—prostate cancer	0.000161	0.000197	CcSEcCtD
Ibandronate—Chills—Epirubicin—prostate cancer	0.000161	0.000197	CcSEcCtD
Ibandronate—Pruritus—Etoposide—prostate cancer	0.000161	0.000197	CcSEcCtD
Ibandronate—Shock—Prednisone—prostate cancer	0.00016	0.000197	CcSEcCtD
Ibandronate—Nervous system disorder—Prednisone—prostate cancer	0.00016	0.000196	CcSEcCtD
Ibandronate—Decreased appetite—Capecitabine—prostate cancer	0.000159	0.000195	CcSEcCtD
Ibandronate—Alopecia—Epirubicin—prostate cancer	0.000159	0.000194	CcSEcCtD
Ibandronate—Skin disorder—Prednisone—prostate cancer	0.000158	0.000194	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000158	0.000194	CcSEcCtD
Ibandronate—Fatigue—Capecitabine—prostate cancer	0.000158	0.000193	CcSEcCtD
Ibandronate—Hyperhidrosis—Prednisone—prostate cancer	0.000158	0.000193	CcSEcCtD
Ibandronate—Mental disorder—Epirubicin—prostate cancer	0.000157	0.000193	CcSEcCtD
Ibandronate—Constipation—Capecitabine—prostate cancer	0.000156	0.000192	CcSEcCtD
Ibandronate—Pain—Capecitabine—prostate cancer	0.000156	0.000192	CcSEcCtD
Ibandronate—Erythema—Epirubicin—prostate cancer	0.000156	0.000192	CcSEcCtD
Ibandronate—Malnutrition—Epirubicin—prostate cancer	0.000156	0.000192	CcSEcCtD
Ibandronate—Feeling abnormal—Docetaxel—prostate cancer	0.000156	0.000191	CcSEcCtD
Ibandronate—Diarrhoea—Etoposide—prostate cancer	0.000156	0.000191	CcSEcCtD
Ibandronate—Eye disorder—Doxorubicin—prostate cancer	0.000155	0.00019	CcSEcCtD
Ibandronate—Gastrointestinal pain—Docetaxel—prostate cancer	0.000155	0.000189	CcSEcCtD
Ibandronate—Cardiac disorder—Doxorubicin—prostate cancer	0.000154	0.000189	CcSEcCtD
Ibandronate—Flatulence—Epirubicin—prostate cancer	0.000154	0.000189	CcSEcCtD
Ibandronate—Dysgeusia—Epirubicin—prostate cancer	0.000153	0.000188	CcSEcCtD
Ibandronate—FDPS—Metabolism—MTHFR—prostate cancer	0.000152	0.00118	CbGpPWpGaD
Ibandronate—Back pain—Epirubicin—prostate cancer	0.000151	0.000185	CcSEcCtD
Ibandronate—Feeling abnormal—Capecitabine—prostate cancer	0.000151	0.000185	CcSEcCtD
Ibandronate—Angiopathy—Doxorubicin—prostate cancer	0.000151	0.000185	CcSEcCtD
Ibandronate—Dizziness—Etoposide—prostate cancer	0.00015	0.000184	CcSEcCtD
Ibandronate—Muscle spasms—Epirubicin—prostate cancer	0.00015	0.000184	CcSEcCtD
Ibandronate—Immune system disorder—Doxorubicin—prostate cancer	0.00015	0.000184	CcSEcCtD
Ibandronate—Gastrointestinal pain—Capecitabine—prostate cancer	0.00015	0.000183	CcSEcCtD
Ibandronate—Mediastinal disorder—Doxorubicin—prostate cancer	0.00015	0.000183	CcSEcCtD
Ibandronate—Abdominal pain—Docetaxel—prostate cancer	0.000149	0.000183	CcSEcCtD
Ibandronate—Body temperature increased—Docetaxel—prostate cancer	0.000149	0.000183	CcSEcCtD
Ibandronate—Chills—Doxorubicin—prostate cancer	0.000149	0.000183	CcSEcCtD
Ibandronate—FDPS—Metabolism—PPARA—prostate cancer	0.000149	0.00116	CbGpPWpGaD
Ibandronate—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000148	0.000182	CcSEcCtD
Ibandronate—Insomnia—Prednisone—prostate cancer	0.000147	0.000181	CcSEcCtD
Ibandronate—Alopecia—Doxorubicin—prostate cancer	0.000147	0.00018	CcSEcCtD
Ibandronate—Paraesthesia—Prednisone—prostate cancer	0.000146	0.000179	CcSEcCtD
Ibandronate—Mental disorder—Doxorubicin—prostate cancer	0.000145	0.000178	CcSEcCtD
Ibandronate—Urticaria—Capecitabine—prostate cancer	0.000145	0.000178	CcSEcCtD
Ibandronate—Ill-defined disorder—Epirubicin—prostate cancer	0.000145	0.000178	CcSEcCtD
Ibandronate—Abdominal pain—Capecitabine—prostate cancer	0.000145	0.000177	CcSEcCtD
Ibandronate—Body temperature increased—Capecitabine—prostate cancer	0.000145	0.000177	CcSEcCtD
Ibandronate—Vomiting—Etoposide—prostate cancer	0.000145	0.000177	CcSEcCtD
Ibandronate—Erythema—Doxorubicin—prostate cancer	0.000145	0.000177	CcSEcCtD
Ibandronate—Malnutrition—Doxorubicin—prostate cancer	0.000145	0.000177	CcSEcCtD
Ibandronate—Anaemia—Epirubicin—prostate cancer	0.000144	0.000177	CcSEcCtD
Ibandronate—Dyspepsia—Prednisone—prostate cancer	0.000143	0.000176	CcSEcCtD
Ibandronate—Rash—Etoposide—prostate cancer	0.000143	0.000176	CcSEcCtD
Ibandronate—Dermatitis—Etoposide—prostate cancer	0.000143	0.000176	CcSEcCtD
Ibandronate—Headache—Etoposide—prostate cancer	0.000142	0.000175	CcSEcCtD
Ibandronate—Flatulence—Doxorubicin—prostate cancer	0.000142	0.000175	CcSEcCtD
Ibandronate—Decreased appetite—Prednisone—prostate cancer	0.000142	0.000174	CcSEcCtD
Ibandronate—Dysgeusia—Doxorubicin—prostate cancer	0.000142	0.000174	CcSEcCtD
Ibandronate—Malaise—Epirubicin—prostate cancer	0.000141	0.000173	CcSEcCtD
Ibandronate—Fatigue—Prednisone—prostate cancer	0.000141	0.000172	CcSEcCtD
Ibandronate—Vertigo—Epirubicin—prostate cancer	0.00014	0.000172	CcSEcCtD
Ibandronate—FDPS—Metabolism—CAV1—prostate cancer	0.00014	0.00109	CbGpPWpGaD
Ibandronate—Back pain—Doxorubicin—prostate cancer	0.00014	0.000171	CcSEcCtD
Ibandronate—Constipation—Prednisone—prostate cancer	0.000139	0.000171	CcSEcCtD
Ibandronate—Hypersensitivity—Docetaxel—prostate cancer	0.000139	0.000171	CcSEcCtD
Ibandronate—Muscle spasms—Doxorubicin—prostate cancer	0.000139	0.00017	CcSEcCtD
Ibandronate—Palpitations—Epirubicin—prostate cancer	0.000138	0.000169	CcSEcCtD
Ibandronate—Asthenia—Docetaxel—prostate cancer	0.000136	0.000166	CcSEcCtD
Ibandronate—Nausea—Etoposide—prostate cancer	0.000135	0.000166	CcSEcCtD
Ibandronate—Hypertension—Epirubicin—prostate cancer	0.000135	0.000165	CcSEcCtD
Ibandronate—Hypersensitivity—Capecitabine—prostate cancer	0.000135	0.000165	CcSEcCtD
Ibandronate—Feeling abnormal—Prednisone—prostate cancer	0.000134	0.000165	CcSEcCtD
Ibandronate—Ill-defined disorder—Doxorubicin—prostate cancer	0.000134	0.000164	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	0.000134	0.00104	CbGpPWpGaD
Ibandronate—Pruritus—Docetaxel—prostate cancer	0.000134	0.000164	CcSEcCtD
Ibandronate—Anaemia—Doxorubicin—prostate cancer	0.000134	0.000164	CcSEcCtD
Ibandronate—Gastrointestinal pain—Prednisone—prostate cancer	0.000133	0.000163	CcSEcCtD
Ibandronate—Arthralgia—Epirubicin—prostate cancer	0.000133	0.000163	CcSEcCtD
Ibandronate—Myalgia—Epirubicin—prostate cancer	0.000133	0.000163	CcSEcCtD
Ibandronate—Chest pain—Epirubicin—prostate cancer	0.000133	0.000163	CcSEcCtD
Ibandronate—Anxiety—Epirubicin—prostate cancer	0.000133	0.000162	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000132	0.000162	CcSEcCtD
Ibandronate—Discomfort—Epirubicin—prostate cancer	0.000131	0.000161	CcSEcCtD
Ibandronate—Asthenia—Capecitabine—prostate cancer	0.000131	0.000161	CcSEcCtD
Ibandronate—Malaise—Doxorubicin—prostate cancer	0.00013	0.00016	CcSEcCtD
Ibandronate—Dry mouth—Epirubicin—prostate cancer	0.00013	0.000159	CcSEcCtD
Ibandronate—Vertigo—Doxorubicin—prostate cancer	0.00013	0.000159	CcSEcCtD
Ibandronate—Urticaria—Prednisone—prostate cancer	0.000129	0.000159	CcSEcCtD
Ibandronate—Pruritus—Capecitabine—prostate cancer	0.000129	0.000159	CcSEcCtD
Ibandronate—Diarrhoea—Docetaxel—prostate cancer	0.000129	0.000159	CcSEcCtD
Ibandronate—Abdominal pain—Prednisone—prostate cancer	0.000129	0.000158	CcSEcCtD
Ibandronate—Body temperature increased—Prednisone—prostate cancer	0.000129	0.000158	CcSEcCtD
Ibandronate—Palpitations—Doxorubicin—prostate cancer	0.000128	0.000157	CcSEcCtD
Ibandronate—FDPS—Metabolism—PIK3CG—prostate cancer	0.000127	0.00099	CbGpPWpGaD
Ibandronate—Anaphylactic shock—Epirubicin—prostate cancer	0.000127	0.000156	CcSEcCtD
Ibandronate—Infection—Epirubicin—prostate cancer	0.000127	0.000155	CcSEcCtD
Ibandronate—Shock—Epirubicin—prostate cancer	0.000125	0.000154	CcSEcCtD
Ibandronate—Diarrhoea—Capecitabine—prostate cancer	0.000125	0.000154	CcSEcCtD
Ibandronate—Nervous system disorder—Epirubicin—prostate cancer	0.000125	0.000153	CcSEcCtD
Ibandronate—Dizziness—Docetaxel—prostate cancer	0.000125	0.000153	CcSEcCtD
Ibandronate—Hypertension—Doxorubicin—prostate cancer	0.000125	0.000153	CcSEcCtD
Ibandronate—Skin disorder—Epirubicin—prostate cancer	0.000124	0.000152	CcSEcCtD
Ibandronate—Hyperhidrosis—Epirubicin—prostate cancer	0.000123	0.000151	CcSEcCtD
Ibandronate—Chest pain—Doxorubicin—prostate cancer	0.000123	0.000151	CcSEcCtD
Ibandronate—Myalgia—Doxorubicin—prostate cancer	0.000123	0.000151	CcSEcCtD
Ibandronate—Arthralgia—Doxorubicin—prostate cancer	0.000123	0.000151	CcSEcCtD
Ibandronate—Anxiety—Doxorubicin—prostate cancer	0.000123	0.00015	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000122	0.00015	CcSEcCtD
Ibandronate—Discomfort—Doxorubicin—prostate cancer	0.000122	0.000149	CcSEcCtD
Ibandronate—Dizziness—Capecitabine—prostate cancer	0.000121	0.000148	CcSEcCtD
Ibandronate—FDPS—Metabolism—INS—prostate cancer	0.000121	0.000937	CbGpPWpGaD
Ibandronate—Dry mouth—Doxorubicin—prostate cancer	0.00012	0.000148	CcSEcCtD
Ibandronate—Vomiting—Docetaxel—prostate cancer	0.00012	0.000147	CcSEcCtD
Ibandronate—Hypersensitivity—Prednisone—prostate cancer	0.00012	0.000147	CcSEcCtD
Ibandronate—Rash—Docetaxel—prostate cancer	0.000119	0.000146	CcSEcCtD
Ibandronate—Dermatitis—Docetaxel—prostate cancer	0.000119	0.000146	CcSEcCtD
Ibandronate—Headache—Docetaxel—prostate cancer	0.000118	0.000145	CcSEcCtD
Ibandronate—FDPS—Metabolism—CREBBP—prostate cancer	0.000118	0.000918	CbGpPWpGaD
Ibandronate—Anaphylactic shock—Doxorubicin—prostate cancer	0.000118	0.000145	CcSEcCtD
Ibandronate—Infection—Doxorubicin—prostate cancer	0.000117	0.000144	CcSEcCtD
Ibandronate—Asthenia—Prednisone—prostate cancer	0.000117	0.000143	CcSEcCtD
Ibandronate—Vomiting—Capecitabine—prostate cancer	0.000116	0.000143	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000116	0.000142	CcSEcCtD
Ibandronate—Shock—Doxorubicin—prostate cancer	0.000116	0.000142	CcSEcCtD
Ibandronate—Nervous system disorder—Doxorubicin—prostate cancer	0.000116	0.000142	CcSEcCtD
Ibandronate—Rash—Capecitabine—prostate cancer	0.000115	0.000141	CcSEcCtD
Ibandronate—Pruritus—Prednisone—prostate cancer	0.000115	0.000141	CcSEcCtD
Ibandronate—Insomnia—Epirubicin—prostate cancer	0.000115	0.000141	CcSEcCtD
Ibandronate—Dermatitis—Capecitabine—prostate cancer	0.000115	0.000141	CcSEcCtD
Ibandronate—Headache—Capecitabine—prostate cancer	0.000115	0.000141	CcSEcCtD
Ibandronate—Skin disorder—Doxorubicin—prostate cancer	0.000115	0.00014	CcSEcCtD
Ibandronate—Paraesthesia—Epirubicin—prostate cancer	0.000114	0.00014	CcSEcCtD
Ibandronate—Hyperhidrosis—Doxorubicin—prostate cancer	0.000114	0.00014	CcSEcCtD
Ibandronate—Nausea—Docetaxel—prostate cancer	0.000112	0.000138	CcSEcCtD
Ibandronate—Dyspepsia—Epirubicin—prostate cancer	0.000112	0.000138	CcSEcCtD
Ibandronate—FDPS—Metabolism—PIK3CD—prostate cancer	0.000112	0.00087	CbGpPWpGaD
Ibandronate—Diarrhoea—Prednisone—prostate cancer	0.000112	0.000137	CcSEcCtD
Ibandronate—Decreased appetite—Epirubicin—prostate cancer	0.000111	0.000136	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Epirubicin—prostate cancer	0.00011	0.000135	CcSEcCtD
Ibandronate—Fatigue—Epirubicin—prostate cancer	0.00011	0.000135	CcSEcCtD
Ibandronate—Pain—Epirubicin—prostate cancer	0.000109	0.000134	CcSEcCtD
Ibandronate—Constipation—Epirubicin—prostate cancer	0.000109	0.000134	CcSEcCtD
Ibandronate—Nausea—Capecitabine—prostate cancer	0.000109	0.000133	CcSEcCtD
Ibandronate—Dizziness—Prednisone—prostate cancer	0.000108	0.000132	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000107	0.000132	CcSEcCtD
Ibandronate—Insomnia—Doxorubicin—prostate cancer	0.000107	0.000131	CcSEcCtD
Ibandronate—Paraesthesia—Doxorubicin—prostate cancer	0.000106	0.00013	CcSEcCtD
Ibandronate—FDPS—Metabolism—NOS3—prostate cancer	0.000106	0.000822	CbGpPWpGaD
Ibandronate—Feeling abnormal—Epirubicin—prostate cancer	0.000105	0.000129	CcSEcCtD
Ibandronate—Gastrointestinal pain—Epirubicin—prostate cancer	0.000104	0.000128	CcSEcCtD
Ibandronate—Dyspepsia—Doxorubicin—prostate cancer	0.000104	0.000127	CcSEcCtD
Ibandronate—Vomiting—Prednisone—prostate cancer	0.000104	0.000127	CcSEcCtD
Ibandronate—Rash—Prednisone—prostate cancer	0.000103	0.000126	CcSEcCtD
Ibandronate—Dermatitis—Prednisone—prostate cancer	0.000103	0.000126	CcSEcCtD
Ibandronate—Decreased appetite—Doxorubicin—prostate cancer	0.000103	0.000126	CcSEcCtD
Ibandronate—Headache—Prednisone—prostate cancer	0.000102	0.000125	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000102	0.000125	CcSEcCtD
Ibandronate—Fatigue—Doxorubicin—prostate cancer	0.000102	0.000125	CcSEcCtD
Ibandronate—Urticaria—Epirubicin—prostate cancer	0.000101	0.000124	CcSEcCtD
Ibandronate—Constipation—Doxorubicin—prostate cancer	0.000101	0.000124	CcSEcCtD
Ibandronate—Pain—Doxorubicin—prostate cancer	0.000101	0.000124	CcSEcCtD
Ibandronate—Body temperature increased—Epirubicin—prostate cancer	0.000101	0.000124	CcSEcCtD
Ibandronate—Abdominal pain—Epirubicin—prostate cancer	0.000101	0.000124	CcSEcCtD
Ibandronate—FDPS—Metabolism—PIK3CB—prostate cancer	9.77e-05	0.000758	CbGpPWpGaD
Ibandronate—Feeling abnormal—Doxorubicin—prostate cancer	9.72e-05	0.000119	CcSEcCtD
Ibandronate—Nausea—Prednisone—prostate cancer	9.68e-05	0.000119	CcSEcCtD
Ibandronate—FDPS—Metabolism—PTGS2—prostate cancer	9.68e-05	0.000751	CbGpPWpGaD
Ibandronate—Gastrointestinal pain—Doxorubicin—prostate cancer	9.64e-05	0.000118	CcSEcCtD
Ibandronate—Hypersensitivity—Epirubicin—prostate cancer	9.39e-05	0.000115	CcSEcCtD
Ibandronate—Urticaria—Doxorubicin—prostate cancer	9.37e-05	0.000115	CcSEcCtD
Ibandronate—Body temperature increased—Doxorubicin—prostate cancer	9.32e-05	0.000114	CcSEcCtD
Ibandronate—Abdominal pain—Doxorubicin—prostate cancer	9.32e-05	0.000114	CcSEcCtD
Ibandronate—Asthenia—Epirubicin—prostate cancer	9.15e-05	0.000112	CcSEcCtD
Ibandronate—Pruritus—Epirubicin—prostate cancer	9.02e-05	0.000111	CcSEcCtD
Ibandronate—Diarrhoea—Epirubicin—prostate cancer	8.72e-05	0.000107	CcSEcCtD
Ibandronate—Hypersensitivity—Doxorubicin—prostate cancer	8.69e-05	0.000107	CcSEcCtD
Ibandronate—Asthenia—Doxorubicin—prostate cancer	8.46e-05	0.000104	CcSEcCtD
Ibandronate—FDPS—Metabolism—PTEN—prostate cancer	8.44e-05	0.000655	CbGpPWpGaD
Ibandronate—Dizziness—Epirubicin—prostate cancer	8.43e-05	0.000103	CcSEcCtD
Ibandronate—Pruritus—Doxorubicin—prostate cancer	8.34e-05	0.000102	CcSEcCtD
Ibandronate—Vomiting—Epirubicin—prostate cancer	8.1e-05	9.94e-05	CcSEcCtD
Ibandronate—Diarrhoea—Doxorubicin—prostate cancer	8.07e-05	9.9e-05	CcSEcCtD
Ibandronate—FDPS—Metabolism—EP300—prostate cancer	8.05e-05	0.000625	CbGpPWpGaD
Ibandronate—Rash—Epirubicin—prostate cancer	8.04e-05	9.86e-05	CcSEcCtD
Ibandronate—Dermatitis—Epirubicin—prostate cancer	8.03e-05	9.85e-05	CcSEcCtD
Ibandronate—Headache—Epirubicin—prostate cancer	7.99e-05	9.79e-05	CcSEcCtD
Ibandronate—Dizziness—Doxorubicin—prostate cancer	7.8e-05	9.56e-05	CcSEcCtD
Ibandronate—Nausea—Epirubicin—prostate cancer	7.57e-05	9.28e-05	CcSEcCtD
Ibandronate—Vomiting—Doxorubicin—prostate cancer	7.5e-05	9.2e-05	CcSEcCtD
Ibandronate—Rash—Doxorubicin—prostate cancer	7.44e-05	9.12e-05	CcSEcCtD
Ibandronate—Dermatitis—Doxorubicin—prostate cancer	7.43e-05	9.11e-05	CcSEcCtD
Ibandronate—Headache—Doxorubicin—prostate cancer	7.39e-05	9.06e-05	CcSEcCtD
Ibandronate—Nausea—Doxorubicin—prostate cancer	7.01e-05	8.59e-05	CcSEcCtD
Ibandronate—FDPS—Metabolism—PIK3CA—prostate cancer	5.95e-05	0.000462	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—AKT1—prostate cancer	4.86e-05	0.000378	CbGpPWpGaD
